Peter Sharis is a Cardiology physician affiliated with Midwest Cardiovascular Research Foundation. OpenAlex indexes 17 publications with 403 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.3%Beta blocker21.8%Metoprolol Succinate49%Metoprolol Tartrate29%Carvedilol15%Atenolol5%Sotalol2%Labetalol Hcl1%Part D<11 patientsNitrate11.8%Isosorbide Mononitrate Er70%Nitroglycerin29%Isosorbide Dinitrate1%Part D<11 patients+ 17 more classes in this area
Blood & clotting
14.2%Factor Xa inhibitor6.3%Eliquis74%Xarelto27%Part D≥80 patientsP2Y12 inhibitor5.3%Clopidogrel94%Brilinta6%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.4%Potassium supplement2.4%Potassium Chloride100%Part D≥56 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center
Vascular Health and Risk Management
2014 - Left main stenting using drug-eluting stents: long term outcome in an unselected cohort of patients from a tertiary medical center stratified by Syntax scoring
Cardiovascular revascularization medicine
2012 - Intermediate term outcomes with bifurcation coronary stenting using the paclitaxel drug-eluting stent: A single centre experience
International Journal of Angiology
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Nicolas Shammas, MD
Midwest Cardiovascular Research Foundation
Eric Dippel, MD
Midwest Cardiovascular Research Foundation
Edmund Coyne, MD
Midwest Cardiovascular Research Foundation
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”